110 results
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
of, (i) any director on our board of directors who is not an employee of the Company or any of its subsidiaries, or (ii) any holder of our Class … A Preferred Stock or any affiliate or other related person of any such holder, other than someone who is an employee of the Company or any of its subsidiaries
8-K
EX-4.2
9i42vk636sihaj4 9v0
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.1
cfgs5bg67qu
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.1
bv284
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.2
js7y5j
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
zkl wp1g55c04va3fv
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.2
noztom
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.3
7a4e eq2hzzl0v
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
7hg4mr83gbb
2 Nov 23
Prospectus supplement with pricing info
9:00am